Key facts
- This page summarizes InnoCare Pharma Inc.'s Form 3 filing for Zenas BioPharma, Inc. (ZBIO).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 Oct 2025, 06:12.
InnoCare Pharma Inc. - 07 Oct 2025 Form 3 Insider Report for Zenas BioPharma, Inc. (ZBIO)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- ZBIO
- Reported as of
- 07 Oct 2025
- Net transaction value
- $0
- Reporting owner signature
- /s/ Jisong Cui, Chairperson and CEO
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
InnoCare Pharma Inc. filed Form 3 for Zenas BioPharma, Inc. (ZBIO) on 15 Oct 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002089568
Primary reporting owner
InnoCare Pharma Inc.
- Relationship
- 10%+ Owner
- Address
- 103 CARNEGIE CENTER, SUITE 209, PRINCETON
- Signature
- /s/ Jisong Cui, Chairperson and CEO
- Signature date
- 15 Oct 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZBIO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 5,000,000
- Date
- 07 Oct 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.